Ref ID: 19563
Author:
E Shagdileeva1*, S Khostelidi1, E Raush1, T Bogomolova1, S Ignatyeva1, N Klimko1
Author address:
1I.I. Metchnikov North-Western State Medical University, Saint-Petersburg, Russia
Full conference title:
6th Advances Against Aspergillosis 2014
Abstract:
Objective:
Invasive aspergillosis (IA) and candidiasis (IA) are leading causes of morbidity and mortality in
haematological patients. Publications about combination of IC and IA in haematological patients
are limited.
Methods:
The prospective study was conducted during the period 2012-2013 y.y. Diagnosis of IA and IC was
made according to EORTC/MSG criteria (2008).
Results:
We observed 3 hematological patients with IA and IC. The mean age of our patients was 42 years
(range 36-58), male and female ratio 1:2. Underlying conditions were: acute myeloid leukemia – 2,
non-Hodgkin’s lymphoma – 1.
Test «Platelia Aspergillus EIA» (Bio-Rad) was positive in all of patients in blood and BAL.
A. flavus in BAL – 1 patient.
Diagnosis of IC was confirmed by culture of blood. The agents of IC were C.krusei, C. parapsilosis
and unidentified Candida.
The main sites of IA and IC were lungs (100%), sinuses (67%), skin and soft tissues – (33%). More
then one organs were affected in all of patients.
Antifungal therapy was performed all of patients: voriconazole – 100%, fluconazole – 67%,
amphotericin B deoxycholate – 67%%, caspofungin – 67%%, amphotericin B lipid complex
– 33%, micafungin – 33%. Combination therapy voriconazole + amphotericin B, voriconazole+
caspofungin, voriconazole+ micafungin was used for 67% patients.
Duration of antifungal therapy was 11 – 167 days (median – 120). Necrosectomy of nasal soft tissues
was performed in 1 patients. Overall survival at 12 weeks was 2/3 of patients.
Conclusion:
Combination therapy can be successful in the treatment of combination of invasive aspergillosis and
candidiasis in haematological patients.
Abstract Number: 90
Conference Year: 2014
Link to conference website: http://www.AAA2014.org
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a